YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AbbVie to buy ImmunoGen for $10B

Posted online

AbbVie reached a deal to buy drug developer ImmunoGen.

The deal is valued at roughly $10 billion.

Through the deal, AbbVie would gain access to Elahere, an ImmunoGen ovarian cancer treatment.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences